New Age Antipsychotic: Iloperidone

@inproceedings{Shah2015NewAA,
  title={New Age Antipsychotic: Iloperidone},
  author={Arpita Shah and Jaykumar Jashvantrai Sejpal and Jigar Ravindrabhai Katwala and Anil Jaiswal and Azadar Khan},
  year={2015}
}
Schizophreniais a heterogeneous, chronic, severe, and disabling brain disorder that has affected people throughout history. Schizophrenia is a severely debilitating psychiatric disorder observed worldwide, with a median lifetime prevalence of 0.7%–1.0%. Iloperidone possesses stronger affinity for serotonin (5- HT2A) than dopamine (D 2 ) receptors, and its efficacy is roughly comparable to that of other (nonclozapine) antipsychotics. In May 2009, the Food and Drug Administration approved… 

Figures and Tables from this paper

Long-term Effectiveness and Tolerability Profile of Iloperidone in Patients of Psychosis
TLDR
It was observed that iloperidone was fairly efficacious not only in preventing relapse or aggravation of symptoms but also well restored the patient to almost near-normal till the end point, and has favorable tolerability profile with modest weight gain and practically no alteration in FBS, and lipid profile as well as absence of extrapyramidal side effects.

References

SHOWING 1-10 OF 26 REFERENCES
Iloperidone: in schizophrenia.
  • L. Scott
  • Psychology, Medicine
    CNS drugs
  • 2009
TLDR
In a pooled analysis of three 52-week, double-blind, multinational, multicentre trials, iloperidone treatment was shown to be equivalent to that with haloperidol, based on Kaplan-Meier estimates of the time to relapse (primary endpoint).
Iloperidone: A new drug for the treatment of schizophrenia.
  • Sally A. Arif, Melissa Mitchell
  • Medicine, Psychology
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
  • 2011
TLDR
Iloperidone may be a viable and safe option for the treatment of schizophrenia in adult patients, especially for patients who cannot tolerate other antipsychotic agents.
Efficacy of Iloperidone in the Treatment of Schizophrenia: Initial Phase 3 Studies
TLDR
This report examines efficacy results from three 6-week, randomized, double-blind, placebo- and active comparator-controlled studies in patients with schizophrenia or schizoaffective disorder and indicates that iloperidone is effective for the treatment of schizophrenia.
Safety Profile of Iloperidone: A Pooled Analysis of 6-Week Acute-Phase Pivotal Trials
TLDR
Short-term trials suggest that iloperidone has a reassuring safety profile in many of the areas that are of potential concern, including relatively low dropout rates because of AEs, low extrapyramidal symptoms, akathisia, and prolactin elevation, and a modest short-term effect on weight gain.
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
TLDR
Olanzapine was the most effective in terms of the rates of discontinuation, and the efficacy of the conventional antipsychotic agent perphenazine appeared similar to that of quetiapine, risperidone, and ziprasidone.
A review of atypical antipsychotic drugs versus conventional medication in schizophrenia
TLDR
Differences in clinical effectiveness and tolerability between conventional and atypical antipsychotic agents are described and some of the more significant adverse effects including tardive dyskinesia, weight gain, diabetes and sudden death are discussed.
The Role of Serotonin in Antipsychotic Drug Action
  • H. Meltzer
  • Psychology, Medicine
    Neuropsychopharmacology
  • 1999
Iloperidone: a clinical overview.
  • L. Citrome
  • Medicine, Psychology
    The Journal of clinical psychiatry
  • 2011
TLDR
The tolerability profile of iloperidone is noteworthy in terms of modest weight gain, no medically important changes in lipid and glucose levels, little in the way of prolactin elevation, and absence of extrapyramidal side effects, including akathisia.
Partial response to antipsychotic treatment: the patient with enduring symptoms.
  • R. Emsley
  • Psychology, Medicine
    The Journal of clinical psychiatry
  • 1999
TLDR
The availability of atypical antipsychotic agents represents a significant step forward for those patients who are nonresponsive to conventional antipsychotics, offering proven efficacy, a lower risk of extrapyramidal symptoms, and improved clinical outcomes.
Long-Term Efficacy and Safety of Iloperidone: Results From 3 Clinical Trials for the Treatment of Schizophrenia
TLDR
Iloperidone demonstrated long-term efficacy equivalent to haloperidol and a favorable long- term safety profile, potentially making this agent a suitable option as maintenance therapy for schizophrenia.
...
...